Currently, albumin is used as a plasma expander to diagnose and treat certain complications of cirrhosis with ascites, such as hepatorenal syndrome. These complications include renal dysfunction brought on by spontaneous bacterial peritonitis and circulatory dysfunction brought on by paracentesis. Recent research has demonstrated that long-term administration of albumin to patients with decompensated cirrhosis lowers mortality and the incidence of complications, makes it easier to manage ascites, is cost-effective, and has a good safety profile. Join us as Takeda presents an interesting discussion about the role of albumin and its significance with eminent doctors like Dr. Shasthry, Dr. Krishna Patil & Dr. Tanuja Mallik.

Role of Albumin in HRS & in Critically Ill Cirhhotics

Additional Professor, Department of Hepatology | ILBS, New Delhi

Dr. Shasthry SM

1

485

7.9k

4.5

Sessions Taken

835

4.5